Bioporto A/S
CSE:BIOPOR
Bioporto A/S
Cash from Investing Activities
Bioporto A/S
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bioporto A/S
CSE:BIOPOR
|
Cash from Investing Activities
-kr246k
|
CAGR 3-Years
44%
|
CAGR 5-Years
31%
|
CAGR 10-Years
15%
|
|
Genmab A/S
CSE:GMAB
|
Cash from Investing Activities
-kr2.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-18%
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Cash from Investing Activities
-kr2.4B
|
CAGR 3-Years
-136%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Cash from Investing Activities
€75.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Cash from Investing Activities
-kr2.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-39%
|
Saniona AB
STO:SANION
|
Cash from Investing Activities
-kr129k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Bioporto A/S's Cash from Investing Activities?
Cash from Investing Activities
-246k
DKK
Based on the financial report for Mar 31, 2024, Bioporto A/S's Cash from Investing Activities amounts to -246k DKK.
What is Bioporto A/S's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
15%
Over the last year, the Cash from Investing Activities growth was -297%. The average annual Cash from Investing Activities growth rates for Bioporto A/S have been 44% over the past three years , 31% over the past five years , and 15% over the past ten years .